The presented data offer new insight on the mechanism of vitamin D anticancer action and, given the fact that both HIF-1 and HIF-2 are validated targets in cancer treatment and prevention, can contribute to the development of the efficient strategies in vitamin D-based cancer therapy. The gene discussed is HIF1A; the disease is cancer.